![New NCI Clinical Trials Program Will Automate Matching Through Third-Party Data Software](https://cdn.cancerletter.com/media/2016/07/art-42-28-moonshot-cover-small.jpg)
![New NCI Clinical Trials Program Will Automate Matching Through Third-Party Data Software](https://cdn.cancerletter.com/media/2016/07/art-42-28-moonshot-cover-small.jpg)
Cover Story
NCI is developing an open-source application intended to make it easier for patients and physicians to get information on clinical trials supported by the institute.
In Brief
![In Brief](https://cdn.cancerletter.com/media/2019/05/03155624/in-brief-3.jpg)
![In Brief](https://cdn.cancerletter.com/media/2019/05/03155624/in-brief-3.jpg)
Drugs & Targets
![Drugs & Targets](https://cdn.cancerletter.com/media/2019/05/03161633/targets2.jpg)
![Drugs & Targets](https://cdn.cancerletter.com/media/2019/05/03161633/targets2.jpg)
Trending Stories
- Before the Olympics were smoke-free, tobacco brand deals ran rampant
- Kamala Harris widely expected to continue Cancer Moonshot; Conservatives present their vision in Project 2025
- How Beth Carner went from six weeks left to live with stage 4 colon cancer to complete remission
- ODAC vote will likely lead to three-arm and four-arm designs–and pragmatic trials–for perioperative indications
- Better oncology drug management could lead to improved outcomes, lower costs
- Tweaking the existing systems is not the answer to drug shortages